Sodium-hydrogen inhibitor cariporide (HOE 642) improves in situ protection of hearts from non-heart-beating donors

Journal of Heart and Lung Transplantation

Volumn 22, Issue 12, 2003, Pages 1335-1342

  Scheule, Albertus M ^a   Jost, Dominik ^a   Beierlein, Wolfram ^a   Zurakowski, David ^b   Haas, Jens ^a   Vogel, Ulrich ^a   Miller, Stefan ^a   Wendel, Hans Peter ^a   Ziemer, Gerhard ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARIPORIDE; MALONALDEHYDE; TROPONIN I; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL TISSUE; AORTA ROOT; ARTICLE; ASCENDING AORTA; CADAVER DONOR; CATHETER; CONTROLLED STUDY; DRUG EFFECT; EXPLANT; HEART ARREST; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HEART RIGHT ATRIUM; HYPOXIA; ISOLATED HEART; MICROSCOPY; MODEL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SWINE; VENTILATOR;

EID: 0346851867     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00027-5     Document Type: Article

References (38)

1. United Network for Organ Sharing. Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989-1998:21-1999:2-2000.
2. Kootstra G., Kievit J.K., Heineman E. The non heart-beating donor. Br Med Bull. 53:1997;844-853.
3. Casavilla A., Ramirez C., Shapiro R., et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation. 59:1995;197-203.
4. Daemen J.H., de Vries B., Oomen A.P., DeMeester J., Kootstra G. Effect of machine perfusion preservation on delayed graft function in non-heart-beating donor kidneys - early results. Transpl Int. 10:1997;317-322.
5. Cope J.T., Mauney M.C., Banks D., et al. Intravenous phenylephrine preconditioning of cardiac grafts from non-heart-beating donors. Ann Thorac Surg. 63:1997;1664-1668.
6. Martin J., Sarai K., Yoshitake M., et al. Successful orthotopic pig heart transplantation from non-heart-beating donors. J Heart Lung Transplant. 18:1999;597-606.
7. Gundry S.R., Alonso de Begona J., Kawauchi M., Liu H., Razzouk A.J., Bailey L.L. Transplantation and reanimation of hearts removed from donors 30 minutes after warm, asystolic 'death.'. Arch Surg. 128:1993;989-991.
8. Gundry S.R., Fukushima N., Eke C.C., Hill A.C., Zuppan C., Bailey L.L. Successful survival of primates receiving transplantation with "dead, " nonbeating donor hearts. J Thorac Cardiovasc Surg. 109:1995;1010-1097.
9. Scheule A.M., Strotmann C., Vogel U., Miller S., Wendel H.P., Ziemer G. Evaluation of a new protection technique for heart preservation of non-heart-beating donors. Transplant Proc. 31:1999;118-119.
10. Scheule A.M., Beierlein W., Jost D., et al. Newly developed catheter set for in situ protection of hearts. Transplant Proc. 33:2001;911-912.
11. Opie L.H. Myocardial stunning - are calcium antagonists useful? Cardiovasc Drugs Ther. 8:(suppl3):1994;533-541.
12. Hendrikx M., Mubagwa K., Verdonck F., et al. New Na(+)-H+ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2+ overload in isolated perfused rabbit heart. Circulation. 89:1994;2787-2798.
13. Scholz W., Albus U., Counillon L., et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 29:1995;260-268.
14. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie. 26:1970;57-60.
15. Sokal R.R., Rohlf F.J. Biometry. The Principles and Practice of Statistics in Biological Research. 3rd ed :1995;275-292 W. H. Freeman, New York.
16. Armitage P., Berry G. Statistical Methods in Medical Research. 3rd ed :1994;297-310 Blackwell Science, Cambridge, MA.
17. Gundry S.R., de Begona J.A., Kawauchi M., Bailey L.L. Successful transplantation of hearts harvested 30 minutes after death from exsanguination. Ann Thorac Surg. 53:1992;772-774.
18. Mauney M.C., Cope J.T., Binns O.A., et al. Non-heart-beating donors a model of thoracic allograft injury . Ann Thorac Surg. 62:1996;54-61.
19. Arnold R.M., Youngner S.J. The dead donor rule should we stretch it, bend it, or abandon it? Kennedy Inst Ethics J. 3:1993;263-278.
20. Lynn J. Are the patients who become organ donors under the Pittsburgh protocol for "non-heart-beating donors" really dead? Kennedy Inst Ethics J. 3:1993;167-178.
21. Cole D. Statutory definitions of death and the management of terminally ill patients who may become organ donors after death. Kennedy Inst Ethics J. 3:1993;145-155.
22. Booster M.H., Wijnen R.M., Ming Y., Vroemen J.P., Kootstra G. In situ perfusion of kidneys from non-heart-beating donors the Maastricht protocol . Transplant Proc. 25:1993;1503-1504.
23. Kootstra G. The asystolic, or non-heartbeating, donor. Transplantation. 63:1997;917-921.
24. de Begona J.A., Gundry S.R., Razzouk A.J., Boucek M.M., Kawauchi M., Bailey L.L. Transplantation of hearts after arrest and resuscitation. Early and long-term results. J Thorac Cardiovasc Surg. 106:1993;1196-1201.
25. Lloveras J., Puig J.M., Cerda M., et al. Newly developed four-lumen catheter for in situ renal perfusion of non-heart-beating donors that provides perfusion pressure monitoring. Transplant Proc. 27:1995;2909-2911.
26. Light J.A., Kowalski A.E., Ritchie W.O., et al. New profile of cadaveric donors what are the kidney donor limits? Transplant Proc. 28:1996;17-20.
27. Light J.A., Kowalski A.E., Sasaki T.M., et al. A rapid organ recovery program for non-heart-beating donors. Transplant Proc. 29:1997;3553-3556.
28. Kootstra G., Daemen J.H., Oomen A.P. Categories of non-heart-beating donors. Transplant Proc. 28:1995;2893-2894.
29. Stromer H., de Groot M.C., Horn M., et al. Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Circulation. 101:2000;2749-2755.
30. Klein H.H., Bohle R.M., Pich S., Lindert-Heimberg S., Wollenweber J., Nebendahl K. Time delay of cell death by Na+/H+-exchange inhibition in regionally ischemic, reperfused porcine hearts. J Cardiovasc Pharmacol. 30:1997;235-240.
31. Turrens J.F., Freeman B.A., Levitt J.G., Crapo J.D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch Biochem Biophys. 217:1982;401-410.
32. Cummins B., Auckland M.L., Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 113:1987;1333-1344.
33. Tritto F.P., Inserte J., Garcia-Dorado D., Ruiz-Meana M., Soler-Soler J. Sodium/hydrogen exchanger inhibition reduces myocardial reperfusion edema after normothermic cardioplegia. J Thorac Cardiovasc Surg. 115:1998;709-715.
34. Scholz W., Albus U. Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy. Cardiovasc Res. 29:1995;184-188.
35. Myers M.L., Karmazyn M. Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694. Ann Thorac Surg. 61:1996;1400-1406.
36. Karmazyn M. The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury. Keio J Med. 47:1998;65-72.
37. Buerke M., Rupprecht H.J., vomDahl J., et al. Sodium-hydrogen exchange inhibition novel strategy to prevent myocardial injury following ischemia and reperfusion . Am J Cardiol. 83:1999;19G-22G.
38. Erhardt L.R. GUARD during ischemia against necrosis (GUARDIAN) trial in acute coronary syndromes. Am J Cardiol. 83:1999;23G-25G.